Changes in microbial and physicochemical properties during free-cell and encapsulated probiotic fermentation of red dragon fruit juice by Ong, Yien Yien

“…The development of probiotic beverage in red dragon fruit juice prolonged the shelf-life of the fruit as well as transforming the fruit juice into a healthy beverage that contains high antioxidant properties (total phenolic content: 29.6 to 31.42 mg/L gallic acid equivalent, ABTS+• inhibition: 12% to 13.1%) and probiotic. …”
Get full text

Liposomal encapsulation of pro-NO donor drug by Koh, Cheryl Jie Yan

“…Liposomes are utilised as drug carrier due to its biocompatibility and inert nature in the physiological body, to protect the drug as well as prevent premature elimination by the body. …”
Get full text

Millifluidic synthesis of amorphous drug-polysaccharide nanoparticle complex with tunable size intended for supersaturating drug delivery applications by Tran, The-Thien, Nguyen, Minh-Hiep, Tan, Yong Zen, Chew, Jia Wei, Khan, Saif A., Hadinoto, Kunn

“…Most importantly, the ability to produce significantly smaller nanoplex (sixfold smaller) via millifluidics led to the generation of higher (≈8.5× of CUR saturation solubility) and prolonged (≈8 h) supersaturation level. These results bode well for the bioavailability enhancement potential of the drug nanoplex.…”
Get full text
Get full text

Targeting the cytochrome oxidases for drug development in mycobacteria by Lee, Bei Shi, Sviriaeva, Ekaterina, Pethe, Kevin

“…In this review, we are discussing current knowledge about the two mycobacterial aerobic respiratory branches, their potential as drug targets, as well as potential drawbacks.…”
Get full text

Fabrication of micro-needles for transdermal drug delivery by Ng, Hui Beng

Get full text

Protein delivery options: how well have we succeeded? by Ng, Xu Wen, Subbu, Venkatraman

Get full text
Get full text

Studies of injectable in situ depot-forming systems for drug delivery by Liu, Hui

“…In this project, injectable in situ depot-forming systems for drug delivery were studied. These systems are composed of a biodegradable polymer poly(D,L-lactide) (PLA) or poly(D,L-lactide-co-glycolide) (PLGA) and a low Mw model drug in an organic solvent. …”
Get full text

Development of biomimetic 3D cancer platform for drug testing by Ker, Sia Fong

Get full text

Recent advances in the development of liquid crystalline nanoparticles as drug delivery systems by Leu, Jassica S. L., Teoh, Jasy J. X., Ling, Angel L. Q., Chong, Joey, Loo, Yan Shan, Mat Azmi, Intan Diana, Zahid, Noor Idayu, Bose, Rajendran J. C., Madheswaran, Thiagarajan

“…In addition, the composition of mesophases can be modified by pore diameters, thus influencing drug release. Much research has been conducted in recent years to improve their preparation and characterization, as well as to control drug release and improve the efficacy of loaded bioactive chemicals. …”
Get full text

Prolonged release of risperidone via gastro retentive drug delivery device by Kwan, Audrey Kai Xin

Get full text

Layer-by-layer assembled micro and nano carriers for drug delivery applications by Mutukumaraswamy Shaillender

“…In nano- or microparticulate drug delivery, both control of the drug release and interaction of the particles with the cellular environment are critical attributes. …”
Get full text

Green amorphous nanoplex as a new supersaturating drug delivery system by Cheow, Wean Sin, Hadinoto, Kunn

“…The roles of salt, drug, and PE in nanoplex formation are examined from ternary phase diagrams of the drug–PE complex, from which the importance of the drug’s charge density and hydrophobicity, as well as the PE ionization at different pH values, is recognized. …”
Get full text
Get full text

Dynamic drug combination methods for suppressing bacterial antibiotics resistance adaptation by Bhone, Myint Kyaw

“…It is resistant to many drugs and the glycopeptide vancomycin is the only available antibiotic that is active against MRSA infections. …”
Get full text

Exploring drug consumption rooms as ‘inclusion health interventions’: policy implications for Europe by Scher, BD, Chrisinger, BW, Humphreys, DK, Shorter, GW

“…Qualitative research on Drug Consumption Rooms (DCRs) has reported various benefits to clients, including increased feelings of well-being, safety and connection, however, few studies have explored in-depth client narratives of belonging and social inclusion. …”

Lancing drug reservoirs into subcutaneous fat to combat obesity and associated metabolic diseases by Than, Aung, Duong, Phan Khanh, Zan, Ping, Liu, Junjie, Leow, Melvin Khee-Shing, Chen, Peng

“…The outstanding therapeutic effects are attributable to highly localized and biphasic drug release, as well as combination therapy based on browning transformation of white fat and enhanced insulin sensitivity.…”
Get full text

Near-infrared light for phototherapy : photothermal induced drug release and tumor ablation by Li, Menghuan

“…Collectively these studies provided robust insights on the application of NIR laser in cancer treatment, as well as expanded our knowledge of nanotechnology in drug delivery research.…”
Get full text

Formulation and in-vitro release study of drug loaded liposomes for treating dry eye disease by Chua, Yan Ni

“…In addition, such drug delivery system have been proven to provide numerous pharmaceutical benefits such as protecting the drugs within its bilayer as well as providing a sustained release of drugs. …”
Get full text

Antibiotic resistance profile, potential drivers and genotype of Escherichia coli, Salmonella sp. and Vibrio sp. isolated from hybrid red tilapia and Asian seabass in the West Coas... by Dewi, Rita Rosmala

Get full text

An iGlu receptor antagonist and its simultaneous use with an anticancer drug for cancer therapy by Luo, Zhong, Li, Peizhou, Tan, Si Yu, Ang, Chung Yen, Nguyen, Kim Truc, Zhao, Yanli

“…The present work demonstrated the feasibility of employing a delivery system to deliver both neuroprotective drug and anticancer drug for efficient anticancer treatment.…”
Get full text
Get full text

Functional genomics reveals an off-target dependency of drug synergy in gastric cancer therapy by Leylek, Ozen, Honeywell, Megan E., Lee, Michael J., Hemann, Michael T., Ozcan, Gulnihal

“…However, realizing the full potential of this approach requires a clear comprehension of the genetic dependencies underlying drug synergy. While the interactions between conventional chemotherapeutics are well-explored, the interplay of molecular-targeted agents with conventional chemotherapeutics remains a frontier in cancer treatment. …”
Get full text